Business Description
Curis Lifesciences Ltd
ISIN : INE1BZN01016
Compare
Compare
Traded in other countries / regions
CURIS.India IPO Date
2025-11-14Description
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.61 | |||||
Equity-to-Asset | 0.58 | |||||
Debt-to-Equity | 0.46 | |||||
Debt-to-EBITDA | 1.9 | |||||
Interest Coverage | 9.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.6 | |||||
Beneish M-Score | -1.59 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 94.9 | |||||
3-Year EBITDA Growth Rate | 127.1 | |||||
3-Year EPS without NRI Growth Rate | 182.3 | |||||
3-Year Book Growth Rate | 261.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 80.34 | |||||
9-Day RSI | 73.54 | |||||
14-Day RSI | 64.45 | |||||
3-1 Month Momentum % | -11.26 | |||||
6-1 Month Momentum % | -0.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.52 | |||||
Quick Ratio | 1.28 | |||||
Cash Ratio | 0.48 | |||||
Days Inventory | 228.62 | |||||
Days Sales Outstanding | 56.87 | |||||
Days Payable | 61.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -6.6 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 30.33 | |||||
Operating Margin % | 17.57 | |||||
Net Margin % | 11.5 | |||||
EBITDA Margin % | 18.94 | |||||
FCF Margin % | -3.08 | |||||
OCF Margin % | -2.93 | |||||
ROE % | 21.75 | |||||
ROA % | 11.15 | |||||
ROIC % | 16.06 | |||||
3-Year ROIIC % | 13.64 | |||||
ROC (Joel Greenblatt) % | 24.23 | |||||
ROCE % | 27.06 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 3.02 | |||||
PE Ratio without NRI | 3.02 | |||||
PS Ratio | 0.34 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 1.91 | |||||
EV-to-EBIT | 9.25 | |||||
EV-to-EBITDA | 8.68 | |||||
EV-to-Revenue | 1.65 | |||||
EV-to-FCF | -53.34 | |||||
Price-to-Graham-Number | 0.51 | |||||
| Price-to-Net-Current-Asset-Value | 2.59 | |||||
Earnings Yield (Greenblatt) % | 10.81 | |||||
FCF Yield % | -2.05 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Curis Lifesciences Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 601.62 | ||
| EPS (TTM) (₹) | 37.14 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 64.45 | ||
| 14-Day ATR (₹) | 1.747768 | ||
| 20-Day SMA (₹) | 103.86 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (₹) | 83.6 - 147.9 | ||
| Shares Outstanding (Mil) | 8.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Curis Lifesciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Curis Lifesciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Curis Lifesciences Ltd Frequently Asked Questions
What is Curis Lifesciences Ltd(NSE:CURIS)'s stock price today?
The current price of NSE:CURIS is ₹112.00. The 52 week high of NSE:CURIS is ₹147.90 and 52 week low is ₹83.60.
When is next earnings date of Curis Lifesciences Ltd(NSE:CURIS)?
The next earnings date of Curis Lifesciences Ltd(NSE:CURIS) is .
Does Curis Lifesciences Ltd(NSE:CURIS) pay dividends? If so, how much?
Curis Lifesciences Ltd(NSE:CURIS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Curis Lifesciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers